TargeGen Spins Out From Forward Venture Program, Raises $10M April 4, 2002 By Karen Young No Comments
TargeGen Spins Out From Forward Venture Program, Raises $10M April 4, 2002 By Karen Young No Comments
Seattle Genetics, Celltech In $30M Antibody Conjugate Deal March 29, 2002 By Karen Young No Comments Celltech Group plc and Seattle Genetics Inc. entered into a multiyear research collaboration to use Seattle Genetics’ antibody-drug conjugate technology with Celltech’s antibody fragments, initially for immunological targets. (BioWorld Today)Read More
